NBP
NovaBridge Biosciences
$2.02
+0.01 (+0.50%)
At close · Jul 7
Market Cap
$536.06M
Shares
265,377,891
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$40,000,000
as of 2025-12-31
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2024-12-31 | $335,000 | 20-F, filed 2026-04-07 |
| 2023-12-31 | $8,644,000 | 20-F, filed 2026-04-07 |
| 2022-12-31 | $3,006,000 | 20-F, filed 2025-04-03 |
| 2021-12-31 | 0 CNY | 20-F, filed 2022-04-29 |
| 2020-12-31 | 34,859,000 CNY | 20-F, filed 2022-04-29 |